In conclusion, our data show that reducing PI3K activity in Drosophila results in hyperglycemia, reduced glycogen content, accumulation of AGEs, oxidative stress, and DNA damage; the latest aspect should be considered as a complication of the anticancer therapies based on PI3K inhibitors. Here, PIK3CB is linked to Hyperglycemia.